-SEC Filing
Amneal Receives FDA Approval For Leuprolide Acetate Injection
Amneal Pharmaceuticals, Inc. (NYSE:AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug